Dialysis mystery: could toxin clearance explain survival boost?

NCT ID NCT06515899

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study looks at why a specific type of dialysis called haemodiafiltration (HDF) improves survival when higher fluid volumes are used. Researchers think it may be because larger waste molecules are removed more effectively and blood pressure stays more stable. They will measure these factors in 342 adults with end-stage kidney disease who are already on HDF. The goal is to see if prescribing dialysis based on toxin clearance rather than volume could help more patients benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If the link is confirmed, doctors might prescribe dialysis based on toxin clearance rather than volume, making treatment more effective for more patients.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The results may not change practice if other factors are at play.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • East and North Hertfordshire NHS Trust

    Stevenage, Hertfordshire, SG1 4AB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.